Duliang Soft Capsule

Duliang Soft Capsule

share

Duliang Soft Capsule

  • product details

  • National Status & Awards

    • Included in the National Reimbursement Drug List (NRDL)

    • Designated as a Protected Traditional Chinese Medicine Product

    • Officially listed in the Pharmacopoeia of the People's Republic of China

    • Selected for the "Torch Program" by the Ministry of Science and Technology

    • Awarded the China Patent Excellence Award

    Global Intellectual Property

    • Granted patents in both China and Singapore

    Pioneering Clinical Research

    • Conducted 5 large-scale Randomized Controlled Trials (RCTs), supported by over 50 peer-reviewed clinical publications, and recommended in 4 authoritative guidelines and expert consensus.

    • The first headache-relief proprietary Chinese medicine with high-level evidence-based medical research proving definitive efficacy.

    • The first headache-relief proprietary Chinese medicine to publish clinical research findings internationally.

    Guideline Inclusions
    Recommended medication in key national medical standards, including:

    • 2016 Chinese Guidelines for the Prevention and Treatment of Migraine

    • TCM Internal Medicine Clinical Diagnosis and Treatment Guidelines: Headache

    Market Leadership

    • Ranked among the Top OTC Medications for Headache and Insomnia in China for consecutive years